1. Histone deacetylase 6 inhibition mitigates renal fibrosis by suppressing TGF-β and EGFR signaling pathways in obstructive nephropathy
   Xingying Chen et al, 2020, American Journal of Physiology-Renal Physiology CrossRef
2. Current treatment strategies targeting histone deacetylase inhibitors in acute lymphocytic leukemia: a systematic review
   Yingjun Zhang et al, 2024, Frontiers in Oncology CrossRef
3. Targeting Epigenetic Modifiers of Tumor Plasticity and Cancer Stem Cell Behavior
   Vigneshwari Easwar Kumar et al, 2022, Cells CrossRef
4. A review of the therapeutic potential of histone deacetylase inhibitors in rhabdomyosarcoma
   Omar Selim et al, 2023, Frontiers in Oncology CrossRef
5. HDAC Inhibition as Neuroprotection in COVID-19 Infection
   Yudibeth Sixto-López et al, 2022, Current Topics in Medicinal Chemistry CrossRef
6. Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy
   Nilanjan Adhikari et al, 2021, Journal of Medicinal Chemistry CrossRef
7. Dose Effects of Histone Deacetylase Inhibitor Tacedinaline (CI-994) on Antipsychotic Haloperidol-Induced Motor and Memory Side Effects in Aged Mice
   Bryan McClarty et al, 2021, Frontiers in Neuroscience CrossRef
8. Combination of Histone Deacetylase Inhibitor Panobinostat (LBH589) with β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both In Vitro and In Vivo
   Ioanna Savvidou et al, 2022, Cancers CrossRef
9. Ferroptosis Induction in Multiple Myeloma Cells Triggers DNA Methylation and Histone Modification Changes Associated with Cellular Senescence
   Emilie Logie et al, 2021, International Journal of Molecular Sciences CrossRef
10. Zingiberene, a non-zinc-binding class I HDAC inhibitor: A novel strategy for the management of neuropathic pain
    Vittoria Borgonetti et al, 2023, Phytomedicine CrossRef